Nureca Return on Equity (ROE) History

Nureca Ltd Return on Equity

The Nureca Ltd Return on Equity is a key financial metric used by investors to evaluate Nureca Ltd's valuation, profitability, and overall financial performance. Tracking the Nureca Ltd Return on Equity helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.

Nureca Ltd (NSE: NURECA, BSE: 543264) is currently trading at ₹295.20, with a market capitalization of ₹2.8B. As a leading company in the Health technology sector and Medical specialties industry, monitoring the Nureca Ltd Return on Equity is essential for fundamental analysis.

Nureca Ltd Return on Equity Current Value

The current Nureca Ltd Return on Equity stands at 0.44.

The latest Nureca Ltd Return on Equity has increased compared to the previous period, indicating rising valuation or improved investor sentiment.

Nureca Ltd Return on Equity Historical Trend

The Nureca Ltd Return on Equity has shown the following historical trend:

• 2024: 0.44
• 2023: -0.92
• 2022: -4.14
• 2021: 24.55
• 2020: 52.10

The recent rise in Nureca Ltd Return on Equity suggests strengthening valuation trends and improving market sentiment.

What Nureca Ltd Return on Equity Indicates for Investors

The Nureca Ltd Return on Equity plays a crucial role in understanding the company's financial health and valuation.

ROE indicates how efficiently the company generates returns for shareholders.

Nureca Ltd Return on Equity Analysis Summary

The Nureca Ltd Return on Equity remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Nureca Ltd Return on Equity should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.

Regular tracking of Nureca Ltd Return on Equity helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.